Document Detail


10t,12c-conjugated linoleic acid inhibits lipopolysaccharide-induced cyclooxygenase expression in vitro and in vivo.
MedLine Citation:
PMID:  16061956     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous data demonstrated that conjugated linoleic acid (CLA) reduced eicosanoid release from select organs. We hypothesized that one active CLA isomer was responsible for the reduced prostaglandin release and that the mechanism was through the inhibition of inducible cyclooxygenase-2 (COX-2). Here, we examined the effects of 10t,12c-CLA and 9c,11t-CLA on COX-2 protein/mRNA expression, prostaglandin E(2) (PGE(2)) production, and the mechanism by which CLA affects COX-2 expression and prostaglandin release. The COX-2 protein expression level was inhibited 80% by 10t, 12c-CLA and 26% by 9c,11t-CLA at 100 microM in vitro. PGE(2) production was decreased from 5.39 to 1.12 ng/2 x 10(6) cells by 10t,12c-CLA and from 5.7 to 4.5 ng/2 x 10(6) cells by 9c,11t-CLA at 100 microM. Mice fed 10t,12c-CLA but not 9c,11t-CLA were found to have a 34% decrease in COX-2 protein and a 43% reduction of PGE(2) release in the lung. 10t,12c-CLA reduced COX-2 mRNA expression level by 30% at 100 microM in vitro and by 30% in mouse lung in vivo. Reduced COX-2 mRNA was attributable to an inhibition of the nuclear factor kappaB (NF-kappaB) pathway by 10t,12c-CLA. These data suggested that the inhibition of NF-kappaB was one of the mechanisms for the reduced COX-2 expression and PGE(2) release by 10t,12c-CLA.
Authors:
Guangming Li; David Barnes; Daniel Butz; Dale Bjorling; Mark E Cook
Related Documents :
20489206 - Leukotriene b(4) blt receptor signaling regulates the level and stability of cyclooxyge...
12050256 - The in vivo control of prostaglandin h synthase-2 messenger ribonucleic acid expression...
11296546 - Differential regulation of interleukin-1 beta-induced cyclooxygenase-2 gene expression ...
21082206 - Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cell...
22226856 - Anti-asthmatic agents alleviate pulmonary edema by upregulating aqp1 and aqp5 expressio...
7521386 - Rapid quantitation of mrna species in ethidium bromide-stained gels of competitive rt-p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-08-01
Journal Detail:
Title:  Journal of lipid research     Volume:  46     ISSN:  0022-2275     ISO Abbreviation:  J. Lipid Res.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-09-19     Completed Date:  2006-01-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376606     Medline TA:  J Lipid Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2134-42     Citation Subset:  IM    
Affiliation:
Molecular and Environmental Toxicology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cell Line
Cyclooxygenase 2 Inhibitors / pharmacology*
Dinoprostone / antagonists & inhibitors,  biosynthesis
I-kappa B Proteins / drug effects
Isomerism
Linoleic Acid / pharmacology
Linoleic Acids, Conjugated / pharmacology*
Lipopolysaccharides / pharmacology
Male
Mice
Mice, Inbred BALB C
Phosphorylation / drug effects
RNA, Messenger / drug effects*
Signal Transduction / drug effects
Chemical
Reg. No./Substance:
0/Cyclooxygenase 2 Inhibitors; 0/I-kappa B Proteins; 0/Linoleic Acids, Conjugated; 0/Lipopolysaccharides; 0/RNA, Messenger; 139874-52-5/NF-kappaB inhibitor alpha; 2197-37-7/Linoleic Acid; 363-24-6/Dinoprostone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism.
Next Document:  A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large cl...